Advertisement
Research Article Free access | 10.1172/JCI118968
Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu
Find articles by Price, S. in: PubMed | Google Scholar
Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu
Find articles by Bailey, J. in: PubMed | Google Scholar
Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu
Find articles by Wang, X. in: PubMed | Google Scholar
Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu
Find articles by Jurkovitz, C. in: PubMed | Google Scholar
Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu
Find articles by England, B. in: PubMed | Google Scholar
Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu
Find articles by Ding, X. in: PubMed | Google Scholar
Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu
Find articles by Phillips, L. in: PubMed | Google Scholar
Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu
Find articles by Mitch, W. in: PubMed | Google Scholar
Published October 15, 1996 - More info
In normal subjects and diabetic patients, insulin suppresses whole body proteolysis suggesting that the loss of lean body mass and muscle wasting in insulinopenia is related to increased muscle protein degradation. To document how insulinopenia affects organ weights and to identify the pathway for accelerated proteolysis in muscle, streptozotocin-treated and vehicle-injected, pair-fed control rats were studied. The weights of liver, adipose tissue, and muscle were decreased while muscle protein degradation was increased 75% by insulinopenia. This proteolytic response was not eliminated by blocking lysosomal function and calcium-dependent proteases at 7 or 3 d after streptozotocin. When ATP synthesis in muscle was inhibited, the rates of proteolysis were reduced to the same level in insulinopenic and control rats suggesting that the ATP-dependent, ubiquitin-proteasome pathway is activated. Additional evidence for activation of this pathway in muscle includes: (a) an inhibitor of proteasome activity eliminated the increased protein degradation; (b) mRNAs encoding ubiquitin and proteasome subunits were increased two- to threefold; and (c) there was increased transcription of the ubiquitin gene. We conclude that the mechanism for muscle protein wasting in insulinopenia includes activation of the ubiquitin-proteasome pathway with increased expression of the ubiquitin gene.